Sandbox:Sogand: Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
!
!
! colspan="11" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
! colspan="18" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
Line 23: Line 23:
!
!
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
!
!
!
!
!
!
!
!
!
!
!
Line 29: Line 36:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-  
|-  
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 1
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diarrhea
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 2
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 2
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 3
Line 35: Line 42:
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 2
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 2
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |fd
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |fd
!HB
!CBC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT
Line 41: Line 48:
!FDP
!FDP
!D-dimer
!D-dimer
!LDH
![[haptoglobin]]
![[Coombs test]]
!PBS
!BUN
!Cr
!S/C
!
!
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pediatric
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pediatric
Line 47: Line 61:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Disseminated intravascular coagulation (DIC)
|Disseminated intravascular coagulation (DIC)
|
|
|
|
|
|
|
|NL/_
|'''↑'''
|'''↑'''
|  '''↑'''
|  '''↑'''
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemolytic uremic syndrome
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 54: Line 97:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| ---
|Hemolitic anemia
| style="background: #F5F5F5; padding: 5px;" |NL/-
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |NL
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |NL
| +
|NL
| +
|↑
|'''↑'''
|'''↑'''
|
|
|'''↑'''
|'''↑'''
|
|
|
| style="background: #F5F5F5; padding: 5px;" | +++
| style="background: #F5F5F5; padding: 5px;" | +++
Line 80: Line 130:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
|
|
|
|
|
|
|
|
|
Line 102: Line 159:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
|
|
|
|
|
|
|
|
|
Line 118: Line 182:
!Symptom 3
!Symptom 3
!Physical exam 1
!Physical exam 1
! colspan="1" rowspan="1" |Physical exam 2
! colspan="1" rowspan="1" |D
!Physical exam 3
!Physical exam 3
!
!
Line 124: Line 188:
!Lab 2
!Lab 2
!Lab 3
!Lab 3
!
!
!
!
!
!
!
!
!
!
!
Line 146: Line 217:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
|
|
|
|
|
|
|
|
|
Line 168: Line 246:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
|
|
|
|
|
|
|
|
|
Line 190: Line 275:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
|
|
|
|
|
|
|
|
|

Revision as of 21:18, 21 August 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]

On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from disseminated intravascular coagulation (DIC) , thrombotic thrombocytopenic purpura (TTP),systemic vasculitis , [disease 4], [disease 5], and [disease 6].

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Occur Histopathology
Diarrhea Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 fd CBC PC PT PTT FDP D-dimer LDH haptoglobin Coombs test PBS BUN Cr S/C Pediatric Adult Imaging 3
Disseminated intravascular coagulation (DIC) NL/_
Hemolytic uremic syndrome Hemolitic anemia NL NL NL +++ +
Thrombotic thrombocytopenic purpura (TTP) + +++
Systemic vasculitis
Diseases Symptom 1 Symptom 2 Symptom 3 Physical exam 1 D Physical exam 3 Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3 Histopathology Gold standard Additional findings
Differential Diagnosis 4
Differential Diagnosis 5
Differential Diagnosis 6

References

Template:WH Template:WS


Pathophysiology

  1. The pathophysiolgy of xxx disease in unknown.
  2. But it may follow xxx pathway
    • It is believed that xxx might work on yyy to produce zz.

Pathology

  • Idiopathic
  • Itarogenic
  • cardiac

Physiology

Classification
Disease

References